標題
返回
確定
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Home
CDMO
#
CDMO
About 7 search results
Sort by Date
Business
PR Newswire
Tsingke Biotech Hosts Shanghai Salon on Oligonucleotide Drugs, Spotlighting Next-Gen RNA Therapeutics
SHANGHAI
PR Newswire
2026-06-30 22:17
Oligonucleotide Therapeutics
Tsingke Biotech
RNA Therapeutics
Business
PR Newswire
Samsung Biologics Releases 2026 ESG Report, Highlighting Progress in Sustainable Operations and Responsible Growth
INCHEON, South Korea
PR Newswire
2026-06-30 19:00
Samsung Biologics
ESG Report
sustainability
Business
PR Newswire
EirGenix Showcases Dual-Track Biosimilars and CDMO Strategy in U.S. Market Push at BIO 2026
SAN DIEGO
PR Newswire
2026-06-30 13:36
EirGenix
CDMO
biosimilars
Business
PR Newswire
CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea's Hub for Pharma, Biopharma, and Health Innovation
SEOUL, South Korea
PR Newswire
2026-06-23 08:00
CPHI/ Hi Korea
Pharma
biopharma
Business
PR Newswire
Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
MUMBAI, India
PR Newswire
2026-06-22 16:57
Piramal Pharma Solutions
CDMO
customer audits
Business
PR Newswire
LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use
INCHEON, South Korea and SAN DIEGO
PR Newswire
2026-06-22 08:00
LOTTE Biologics
Songdo Bio Campus
CDMO
Business
PR Newswire
Stronger Together, Shaping the Future | WuXi XDC and BioDlink Successfully Concluded 2026 Open Day
SUZHOU, China
PR Newswire
2026-06-04 20:30
WuXi XDC
BioDlink
CRDMO